Depo-Provera

What is Depo-Provera?

Is it safe? What are Depo-Provera side effects? Do you have osteoporosis, low bone density, infertility?
www.monheit.com/whatis.asp

1991 WHO Depo Provera Study

In 1991 after DEPO PROVERA is being used by women in more than 90 countries, the World Health Organization (WHO) concluded that – overall – women taking DEPO PROVERA do not have an increased risk of breast cancer. In addition, breast cancer risk did not increase the longer a woman stayed on the contraceptive by injection DEPO PROVERA. The study did find a slight increase in the risk of breast cancer during the first four years of use, primarily in women under 35. Somehow the WHO concluded that the statistics against DEPO PROVERA were weak and dismissed them.

But the National Women's Health Network disagrees with the DEPO PROVERA research conclusions. In testimony presented to FDA's Fertility and Maternal Health Drugs Advisory Committee a representative of the National Women's Health Network said that the WHO studies were conducted in countries where breast cancer rates were less than half that of the United States and therefore could not be accurately applied to women in this country. Also comparing the breast cancer risk to that associated with oral contraceptives is also misleading because DEPO PROVERA is taken by injection every 12 weeks. Only three epidemiologic studies have been done on Depo Provera and breast cancer and all three raise a red flag with disturbing results.

DEPO PROVERA Questionnaire
Please take the time to answer the questionnaire if you have or had osteoporosis, osteo-related side effects, or other side effects from taking Depo Provera and if you are interested in learning more about your legal rights against Pfizer, Inc. the manufacturer of Depo-Provera. Your inquiry is appreciated and we will follow up in a timely manner.
 

NOTICE: As of 8-31-2007, We Are No Longer Accepting New Depo Provera Case Inquiries.